5 High Growth Pharma Stocks that are Profitable

Page 5 of 5

1. SIGA Technologies, Inc. (NASDAQ:SIGA)

Q/Q Sales Growth: 1,400%

Number of Hedge Fund Holders in Q3 2022: 15

SIGA Technologies, Inc. (NASDAQ:SIGA) is a pharmaceutical company authorized to sell its products, which include a smallpox treatment, alongside others covering monkeypox and cowpox.

SIGA Technologies, Inc. (NASDAQ:SIGA) had a bumper third quarter of 2022 as its revenues stood at $72 million. When compared to the year ago quarter’s net sales of $4.8 million, this marked a stunning 1,400% annual growth. As of 2022’s third quarter, 15 of the 920 hedge funds polled by Insider Monkey had bought the firm’s shares.

SIGA Technologies, Inc. (NASDAQ:SIGA)’s largest hedge fund shareholder in our database is Touk Sinantha’s AltraVue Capital which owns 1.7 million shares that are worth $12 million.

Follow Siga Technologies Inc (OTCMKTS:SIGA)

Disclosure: None. You can also take a peek at 15 Biggest Insurance Companies in the World and 10 Best Performing Warren Buffett Stocks in 2023.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5